WBA
66
13
SYF
83
-5
EQR
42
-3
PRU
51
-2
MRK
30
-8
MHK
34
-2
VFC
53
-6
GILD
54
4
AIZ
64
-4
HCP
43
-2
ROST
68
-2
CAT
58
-4
BMY
48
-3
NKE
36
-3
SYY
50
-3
LYB
39
2
URI
49
-7
CA
44
-10
NRG
37
-7
MKC
65
2
WBA
66
13
SYF
83
-5
EQR
42
-3
PRU
51
-2
MRK
30
-8
MHK
34
-2
VFC
53
-6
GILD
54
4
AIZ
64
-4
HCP
43
-2
ROST
68
-2
CAT
58
-4
BMY
48
-3
NKE
36
-3
SYY
50
-3
LYB
39
2
URI
49
-7
CA
44
-10
NRG
37
-7
MKC
65
2
Financhill
Back

First Financial Northwest Vs. Aligos Therapeutics Industry Stock Comparison

Sell
28

FFNW
First Financial Northwest

Last Price:
22.53
Seasonality Move:
11.34%
Buy
74

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Sell
28
First Financial Northwest (FFNW) is a Sell

Is First Financial Northwest a Buy, Sell or Hold?

  • The current First Financial Northwest [FFNW] share price is $22.31. The Score for FFNW is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • FFNW is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FFNW Stock Price Chart

What is First Financial Northwest's stock price today?

  • The First Financial Northwest share price today is $22.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FFNW is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $30.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FFNW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 46.15 Sell
Chaikin Money Flow: -8468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.19 - 22.61) Sell
Bollinger Bands (100): (21.9 - 22.78) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.32 Buy
Relative Strength Index (14 RSI): 81.62 Buy
Chaikin Money Flow: 315379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.3 - 26.46) Buy
Bollinger Bands (100): (7.85 - 19.03) Buy

FFNW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.38 Sell
20-day SMA: 22.39 Sell
50-day SMA: 22.52 Sell
200-day SMA: 21.59 Buy
8-day EMA: 22.36 Sell
20-day EMA: 22.41 Sell
50-day EMA: 22.42 Sell
200-day EMA: 21 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.35 Buy
20-day SMA: 22.81 Buy
50-day SMA: 14.24 Buy
200-day SMA: 15.81 Buy
8-day EMA: 27.13 Buy
20-day EMA: 22.88 Buy
50-day EMA: 17.49 Buy
200-day EMA: 15.94 Buy

First Financial Northwest Earnings Growth & FFNW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and an increase next year of $0.19 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

First Financial Northwest Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):